Domain Expertise – Project & Portfolio Management | Portfolio Selection by Optimization and Prioritization | Decision Analysis | Decision-making Under Risk & Uncertainty | Risk Analysis & Risk Management | Asset Valuation & Options Analysis | Strategic Planning | Licensing & Business Development | Drug Discovery & Development | Training and Facilitation. - Seasoned executive with 23 years of corporate experience and 6 years in consulting focused on enabling complex project and portfolio investment decisions under conditions of risk and uncertainty. - Previous position – Vice President, Portfolio Management & Decision Analysis, Johnson & Johnson Pharmaceutical Research & Development. - Regarded as a leading practitioner of Risk Management and Project Portfolio Management in the Pharma & Biotech industry and created a unique Portfolio Management framework (CREOPM) which has been successfully applied to several industry sectors as evidenced by ~15% annual increase in top and bottom line financial performance. - Distinguished by my application of CREOPM to maximize enterprise portfolio value under constrained financial and human resources in risky and uncertain environments. - Co-authored book titled 'Enterprise Project Portfolio Management: Building Competencies For R&D And IT Investment Success' (J. Ross; 2012), the basis of which is CREOPM. - International trainer and facilitator in Risk Analysis, Decision Analysis, Portfolio Management, and Project Leadership. - Built and led Strategic Planning and Portfolio Management departments for 11 years at Bayer, Bristol-Myers Squibb, and Johnson & Johnson. - 2 years as International Project Manager for marketed cardiovascular drug. - Adjunct faculty at (a) University of Pennsylvania lecturing in Project Portfolio Management and (b) Stevens Institute of Technology lecturing in Project Leadership. - M.Sc. and Ph.D. from University of London, MBA from Columbia University, and PMP from Project Management Institute. Specialties: Project & Portfolio Management; Risk Analysis & Risk Management; Asset Valuation; Strategic Planning; Business Planning; Licensing & Business Development; Decision Analysis; Drug Discovery, Development & Commercialization